Catheter Precision announced that LockeT was used for the first time outside of the United States at Hamad Medical Corporation Heart Hospital in Doha, Qatar. Hamad Medical Corporation is the main provider of secondary and tertiary healthcare in Qatar and one of the leading hospital providers in the Middle East. HMC manages 12 hospitals – nine specialist hospitals and three community hospitals.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on VTAK:
- Catheter Precision announces first use of VIVO with pediatric patient
- Catheter Precision Converts Preferred Stock to Common Shares
- Catheter Precision enters distribution agreement in Turkey
- Catheter Precision enters distribution agreement with SUPRI
- Catheter Precision announces publication featuring VIVO System